Orlistat and Weight Management for Uric Acid Control in Obese Gout: A RCT
Orlistat and Weight Management for Uric Acid Control in Obese Gout: A RCT
Not yet recruiting · NCT07326839 · Registry updated 2026-01-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Orlistat and Weight Management for Uric Acid Control in Obese Gout: A RCT | Body Weight, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, nutritional disorder, obesity disorder, overnutrition, rheumatic disorder | Not yet recruiting | Not applicable | 2026-01-08 | NCT07326839 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shengjing Hospital | 111 |
| The People's Hospital of Liaoning Province | 3 |
| XueMei Guo | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| General Hospital of Northern Theater Command, PLA | Shenyang | China | 1 |